• About us
• Contact

Advertisement

Organisation › Details

WuXi PharmaTech (Group)

The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. WuXi PharmaTech (NYSE: WX) is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customerfocused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. *

 

	Start	2000-12-01 established
	Industry	drug discovery
	Industry 2	chemical compound library (production)
	Region	Shanghai
	Country	China
	Street	288 Fute Zhong Road, Wai gaoqiao Free Trade Zone
	City	200131 Shanghai
	Tel	+86-21-5046-1111
		Address record changed: 2020-12-02
Basic data	Employees	F: 1,001 to 5,000 (2010-05-25)
		* Document for »About Section«:
		Record changed: 2024-08-24

Advertisement

More documents for WuXi PharmaTech (Group)

• [1] Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel....
• [2] Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried....
• [3] WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai....
• [4] Genezen, Inc.. (1/26/22). "Press Release: Genezen Appoints Senior Director of Business Development"....
• [5] Bristol-Myers Squibb Company. (8/3/21). "Press Release: Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland". New York, NY....
• [6] Metrion Biosciences Ltd.. (7/26/21). "Press Release: Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development". Cambridge....
• [7] WuXi AppTec. (7/20/21). Web Page: WuXi Global Forum 2021. [https://www.wuxiapptec.com, 07/20/21]...
• [8] WuXi AppTec. (7/20/21). Web Page: WuXi Healthcare Forum 2021. [https://www.wuxiapptec.com, 07/20/21]...
• [9] Oxford Genetics Ltd.. (3/2/21). "Press Release: WuXi AppTec Completes Acquisition of Oxgene to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers". Philadeliphia, PA & Oxford....
• [10] Almirall S.A.. (1/9/20). "Press Release: Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases". Barcelona....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.